The Drug-Device Combination Market, By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others), Application Type (Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest Of Asia-Pacific) Industry Trends and Forecast To 2028.
Market Analysis and Insights: Asia-Pacific Drug-Device Combination Market
The drug-device combination market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2021 to 2028 and is expected to reach USD 3,332.81 million by 2028 from USD 1,703.67 million in 2020. Increasing chronic disease burden and growing demand for better drug-device combinations are the major drivers that drive the market demand in the forecast period.
The increasing prevalence of chronic diseases and advancement in technology effectively help the growth of the drug-device combination market. However, the limitations and complications associated with the medical devices may hamper the future growth of the medical devices market. Major market players' partnerships and collaborations act as an opportunity for the growth of the drug-device combination market. However, strict regulatory framework acts a challenge for the growth of the drug-device combination market.
The drug-device combination market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Asia-Pacific Drug-Device Combination Market Scope and Market Size
The drug-device combination market is categorized into four notable segments which are based on product, application, end user, and distribution channel.
- On the basis of product, the drug-device combination market is segmented into auto-injector, microneedle patch, digital pill, smart inhaler, drug delivery hydrogels, drug-eluting lens, and others. In 2021, auto-injector holds the highest share in the drug-device combination market as the rise in government support in developing healthcare products and raising general awareness about usage amongst the masses.
- On the basis of application, the drug-device combination market is segmented into orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, and others. In 2021 orthopedic diseases dominate the drug-device combination market due to the growing demand for highly advanced and efficient drug-device combination products for treatment.
- On the basis of end user, the drug-device combination market is segmented into clinics, hospitals, home care settings, ambulatory care centers, and others. In 2021, the clinics are expected to dominate the drug-device combination market due to the increasing number of specialty clinics worldwide. Furthermore, the growing demand for various drug-delivery devices serves as another driving factor.
- On the basis of distribution channel, the drug-device combination market is segmented into direct tender, retail sales, and others. In 2021, direct tender is expected to dominate the drug-device combination market due to the increasing number of hospitals in developed and developing countries, which increases the sales of direct tender and escalates the growth of the market.
Asia-Pacific Drug-Device Combination Market Country Level Analysis
The drug-device combination market is analyzed, and market size information is provided by product, application, end user, and distribution channel.
The countries covered in the drug-device market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.
Asia-Pacific is expected to grow with the fastest CAGR in the forecasted periods. In Asia-Pacific, countries that demand drug-device combination are increasing rapidly due to increasing population and healthcare expenditure. China is expected to dominate in Asia-Pacific market. China is one of the leading countries in the Asia-Pacific, which utilizes advanced drug-device combination products in the treatment and monitoring of disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufactures is Creating New Opportunities for Players in the Drug-Device Combination Market
Drug-device combination market also provides you with detailed market analysis for every country's growth. Moreover, it provides detailed data regarding growth in medical devices sales, partnership, acquisition, distribution agreement among the market players of Asia-Pacific region. The data is available for the historic period 2010 to 2019.
Competitive Landscape and Drug-Device Combination Market - Share Analysis
Drug-device combination market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the drug-device combination market.
The major players covered in the reports are Medtronic, GlaxoSmithKline plc, BD, Janssen Pharmaceuticals, Inc., Bayer AG, YPSOMED, CosMED Pharmaceutical Co. Ltd., Otsuka America Pharmaceutical,Inc, VAXXAS ,Raphas Co., Ltd., Zimmer Biomet, SONCEBOZ, CGbio, EOFLOW CO.,LTD, among others are domestic and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and product launches are also initiated by companies worldwide, accelerating the drug-device combination market.
For instance,
- In November 2020, YPSOMED collaborated with SCHOTT and Lonza to develop a comprehensive solution for wearable patch injectors and combination products based on subcutaneous self-injection. This helped a firm enter into clinical trials and marketed the products quicker, which boosted the market
- In June 2017, CosMED Pharmaceutical Co. Ltd. launched and started the sales of microneedle hair growers,”fa:sa”. This enhanced the growth of the firm in microneedle technology
Collaboration, joint ventures, and other strategies by the market player enhance the company's impression in the Medical devices market, which also benefits the organization to improve their sales growth.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATENT ANALYSIS
4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS
4.1.2 APPROVAL BY AGENCY
4.1.3 PATENT GRANT
4.1.4 PATENT CERTIFICATIONS:
5 PIPELINE ANALYSIS
6 REGULATORY FRAMEWORKS:
6.1 U.S.
6.2 EUROPE
6.3 CANADA
6.4 AUSTRALIA
6.5 JAPAN
6.6 CHINA
6.7 SOUTH KOREA
7 REGIONAL SUMMARY
7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.1.1 OVERVIEW
7.2 EUROPE DRUG-DEVICE COMBINATION MARKET
7.2.1 OVERVIEW
7.3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
7.3.1 OVERVIEW
7.4 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET
7.4.1 OVERVIEW
7.5 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.5.1 OVERVIEW
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
8.1.2 GROWING GERIATRIC POPULATION
8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
8.1.4 RISING RATES OF OBESITY
8.2 RESTRAINTS
8.2.1 PRODUCT RECALLS
8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS
8.3 OPPORTUNITIES
8.3.1 RISING EXPENDITURE ON HEALTHCARE
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES
8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
8.4 CHALLENGE
8.4.1 STRICT REGULATORY FRAMEWORK
9 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON SUPPLY CHAIN
9.3 IMPACT ON DEMAND
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 AUTO-INJECTOR
10.2.1 WEARABLE AUTO-INJECTOR
10.2.2 HAND HELD AUTO-INJECTOR
10.3 MICRONEEDLE PATCH
10.4 DIGITAL PILL
10.5 SMART INHALER
10.6 DRUG DELIVERY HYDROGELS
10.7 DRUG-ELUTING LENS
10.8 OTHERS
11 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ORTHOPEDIC DISEASES
11.3 RESPIRATORY DISEASES
11.4 DIABETES
11.5 ONCOLOGY
11.6 CARDIOVASCULAR DISEASES
11.7 OTHERS
12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOSPITALS
12.4 HOME CARE SETTINGS
12.5 AMBULATORY CARE CENTERS
12.6 OTHERS
13 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAILS SALES
13.4 OTHERS
14 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 JAPAN
14.1.2 CHINA
14.1.3 SOUTH KOREA
14.1.4 INDIA
14.1.5 AUSTRALIA
14.1.6 SINGAPORE
14.1.7 THAILAND
14.1.8 MALAYSIA
14.1.9 INDONESIA
14.1.10 PHILIPPINES
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 AMGEN INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 GLAXOSMITHKLINE PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BD
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 MEDTRONIC
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 BAYER AG
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 CGBIO
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 COSMED PHARMACEUTICAL CO.LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 E3D ELCAM DRUG DELIVERY DEVICES
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 EITAN MEDICAL
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 EOFLOW CO., LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 FINDAIR SP. Z O. O.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 INSULET CORPORATION
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 MEDIPRINT
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 METP PHARMA AG
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 MICRON BIOMEDICAL, INC.
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 NANOPASS
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 OCUMEDIC
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 OTSUKA AMERICA PHARMACEUTICAL, INC.
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 PROPELLER HEALTH
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 RAPHAS CO., LTD.
17.21.1 COMPANY SNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENT
17.22 SENSIRION AG SWITZERLAND
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 . SONCEBOZ
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 SUBCUJECT APS
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 THERAJECT
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
17.26 VAXESS TECHNOLOGIES INC.
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 VAXXAS
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 YPSOMED
17.28.1 COMPANY SNAPSHOT
17.28.2 REVENUE ANALYSIS
17.28.3 PRODUCT PORTFOLIO
17.28.4 RECENT DEVELOPMENTS
17.29 ZIMMER BIOMET
17.29.1 COMPANY SNAPSHOT
17.29.2 REVENUE ANALYSIS
17.29.3 PRODUCT PORTFOLIO
17.29.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 ASIA-PACIFIC DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS
TABLE 2 MOST OBESE COUNTRIES OF ASIA-PACIFIC 2020
TABLE 3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC MICRONEEDLE PATCH IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC DIGITAL PILL IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC SMART INHALER IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC DRUG DELIVERY HYDROGELS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC DRUG-ELUTING LENS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ORTHOPEDIC DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC RESPIRATORY DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC DIABETES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC ONCOLOGY IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CLINICS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC HOSPITALS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC HOME CARE SETTINGS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC DIRECT TENDER IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC RETAIL SALES IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 35 JAPAN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 36 JAPAN AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 37 JAPAN DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 38 JAPAN DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 JAPAN DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 CHINA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 41 CHINA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 42 CHINA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 CHINA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 CHINA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 46 SOUTH KOREA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 47 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 49 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 INDIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 51 INDIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 52 INDIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 53 INDIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 INDIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 AUSTRALIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 61 SINGAPORE AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 62 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 63 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 64 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 65 THAILAND DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 66 THAILAND AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 67 THAILAND DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 THAILAND DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 THAILAND DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 71 MALAYSIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 72 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 75 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 INDONESIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 77 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 81 PHILIPPINES AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 82 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE
FIGURE 8 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028
FIGURE 15 PORTER'S 5 FORCES
FIGURE 16 PESTEL'S MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET
FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.
FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 20 AGEING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 21 NORTH AMERICA AGEING POPULATION (IN MILLION)
FIGURE 22 EUROPE AGEING POPULATION (IN MILLION)
FIGURE 23 ASIA-PACIFIC AGEING POPULATION (IN MILLION)
FIGURE 24 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016
FIGURE 25 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020
FIGURE 26 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 27 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 28 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020
FIGURE 30 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 31 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020
FIGURE 34 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2021-2028 (USD MILLION)
FIGURE 35 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 36 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 38 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 39 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 40 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 42 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 43 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 44 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 45 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)
FIGURE 46 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
